The 2022 ELRIG Research & Innovation conference will discuss how cutting edge science continues to be identified and explore how emerging technologies will enable this science to be translated into successful therapeutics. The four sessions will address different aspects of innovation across drug discovery and place an emphasis on both the digital age and novel modalities.

• Omics technology innovations
  Exciting advances in omics has transformed drug discovery. This session will focus on technologies that generate smart, dynamic and unbiased data.
• The future of therapeutic genome engineering Over the last few years, the exuberant development of genome editing technologies has revolutionised drug discovery and targeted therapy of human diseases. This session will focus on most recent advances innovations in therapeutic genome engineering.
• Drug discovery in the digital age
  Networks of cross-discipline researchers are becoming increasingly armed with powerful virtual technologies at different stages of drug discovery and innovative tools for collaboration, this session will discuss the new innovations that will continue to drive drug discovery in the digital age.
• RNA therapeutics & RNA targets at the forefront    Recent success with RNA-based vaccines has propelled RNA technologies to the forefront of drug discovery research. This session will focus on innovations in the field to highlight both the next wave of therapeutic RNA-based technologies alongside progress in modulating RNA targets to treat disease.